ArticleVirchows Archiv : an international journal of pathology2021

Predictive significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, for resistance to trastuzumab-based treatments for HER2-positive breast cancer.

Rie Horii et al.PubMed ↗Publisher ↗

No numbers read from the abstract.